Berenberg cuts CTS Eventim stock price target to EUR115 on temporary costs

Berenberg reduced its price target for CTS Eventim (ETR:EVD) to EUR115.00 from EUR120.00, while maintaining a Buy rating, following the company's weak second-quarter 2025 results driven by Live Entertainment cost pressures and acquisition integration costs. Despite cutting mid-term EPS estimates, the firm views these issues as largely temporary and considers EVD a 'high-quality compounder' whose recent ~20% share price decline is unjustified, projecting approximately 40% upside potential from the new target.

Analysis

Berenberg has reduced its price target on CTS Eventim (ETR:EVD) to EUR115.00 from EUR120.00 but has notably maintained its Buy rating. The target adjustment is a direct response to weak second-quarter 2025 results, which the firm attributes to temporary factors, namely cost pressures within the Live Entertainment segment and integration costs following the acquisitions of SeeTickets and France Billet. Despite these headwinds prompting a high-single-digit percentage cut to mid-term EPS estimates, Berenberg's core thesis remains intact. The firm characterizes CTS Eventim as a 'high-quality compounder with strong barriers to entry' and views the recent approximate 20% decline in its share price as an overreaction and unjustified. The new price target implies a significant upside potential of approximately 40% from the stock's current level, signaling strong conviction in the company's long-term prospects beyond the immediate challenges.

Key Decisions for Investors

• Investors may consider the recent 20% share price drop an attractive entry point, given Berenberg's view that the decline is unjustified and its reaffirmed 'Buy' rating implies 40% upside to the new EUR115.00 target.
• It is critical to monitor upcoming quarterly results for signs that the cost pressures in Live Entertainment and M&A integration costs are indeed abating, as the 'temporary' nature of these issues is key to the analyst's bullish thesis.
• The investment case relies on viewing CTS Eventim as a long-term 'high-quality compounder', meaning any position should be weighed against the company's fundamental market strength rather than solely on the short-term earnings weakness.